|
|
|
|
Welcome to MultiCASE Inc, the leading provider of artificial intelligence based bioactivity software, expert systems and in-silico consulting services for the Chemical and Pharmaceutical Industries
Our MissionWe develop and license computer programs designed to assess the potential pharmacological activity, toxicity and metabolic transformation of new chemicals without using animal tests. We also offer consulting services related to the safety of chemicals and addressing REACH submissions.
Company ProfileMultiCASE Inc. (formerly BIOSOFT Inc.) is a Software company started in Cleveland Ohio in 1996. The principal is Gilles Klopman, the Charles F. Mabery Professor of Chemistry at Case Western Reserve University (CWRU). Its business is to develop and license programs for use by chemical and pharmaceutical companies to design new useful molecules and to evaluate their impact on the environment at an early stage of development. the data for many of our expert systems have been developed by the US Food and Drug Administration ICSAS office and is used by many many government regulatory agencies such as US, Canadian, Japan, Danish and the OECD in conjunction with the REACH program..
|
 | We have acquired a new set of FDA ICSAS human adverse effect modules: Hepatobiliary, Renal and Urinary Tract and Cardiac Adverse Effects in Humans |
| MultiCASE inc has joined Insilico First, a unique collaborative endeavor, working to develop a pioneering computational prediction system to support the environmental safety assessment of chemicals. June 1st, 2008. |
| Version 2.0 of our software products has been released on May 15, 2008 |
| We have acquired a new set of FDA ICSAS teratogenicity modules. |
| List of modules was updated to include all newly acquired and updated in 2006 modules. |
| MCWeb - an online version of MC4PC and CaseTox was launched. |
| ACS Expo in Atlanta. See details. |
| ToxExpo2006 in San Diego. See details. |
| ToxExpo2005 in New Orleans. See details. |
| Fifth contributor joined our Mutagenicity Data Sharing consortium. See details. |
| Renewed CRADA with the FDA...See details. |
| First release of ToxLite - the most affordable version of CASETOX. See details. |
| Three more participants joined the Mutagenicity Data Sharing Consortium. See details. |
|
Send mail to
saiakhov@multicase.com with
questions or comments about this web site.
|
Latest News